Rennovia develops catalysts and scalable chemical catalytic process technologies to produce commodity and specialty chemicals from renewable feedstocks. The company's initial target products are nylon intermediates adipic acid and hexamethylenediamine (HMD). Founded in 2009 and headquartered in Menlo Park, CA, Rennovia focuses on high-yield, low-conversion-cost routes intended to be cost-advantaged versus current petrochemical processes. Rennovia is working to scale up and commercialize its bio-based chemical process technologies. The company is privately held and pursuing research and development to advance its processes. ADM's investment is positioned to help Rennovia commercialize its technologies and access attractive end markets in nylons and other materials.

Total raised

$25M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2014